Search results for "Cancer"
European trial finds reduction in cancers but not deaths with invitation to colonoscopy screening
Healthy patients in Poland, Norway, and Sweden were randomized to usual care or an invitation to screening colonoscopy; only 42% of invited patients responded. The invited group had an 18% lower risk of colorectal cancer at 10 years compared to the usual care group.
https://immattersacp.org/weekly/archives/2022/10/18/4.htm
18 Oct 2022
Use of newer combined hormonal contraceptives may be associated with reduced ovarian cancer risk
The risk reduction was greater with increasing duration of use and persisted for several years after discontinuation, although there was no observed effect with use of progestogen-only products.
https://immattersacp.org/weekly/archives/2018/10/02/3.htm
2 Oct 2018
European guidelines for breast cancer screening differ from U.S. recommendations
The guidelines pertain to organized screening programs for women ages 40 to 75 years who are at average risk for breast cancer and address screening type and frequency, as well as follow-up of abnormal results.
https://immattersacp.org/weekly/archives/2019/11/26/4.htm
26 Nov 2019
MKSAP Quiz: Management of a metastatic neuroendocrine tumor
A 48-year-old woman is evaluated following the diagnosis of a metastatic neuroendocrine tumor. Two weeks ago, she underwent ultrasonography for biliary colic, which unexpectedly showed multiple hepatic lesions. Following tests, a physical exam, and lab studies, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2022/03/22/3.htm
22 Mar 2022
MKSAP Quiz: 1-month history of fever, malaise, weight loss
A 52-year-old woman is evaluated for a 1-month history of fever, malaise, and weight loss. She has a history of cardiomyopathy, for which she received a heart transplant 5 years ago; 3 months ago, an episode of rejection occurred, and high-dose glucocorticoids were initiated. Following a physical exam and CT scan, which infection is the most likely cause of the patient's findings?
https://immattersacp.org/weekly/archives/2024/02/27/3.htm
27 Feb 2024
Four risk prediction models found most accurate for guiding lung cancer screening
These models picked similar numbers of patients who had ever smoked, showed better agreement on size of the screening population, and achieved consensus on 73% of persons chosen, while the other five models generally overestimated risk.
https://immattersacp.org/weekly/archives/2018/05/15/2.htm
15 May 2018
MKSAP Quiz: Follow-up evaluation for colon cancer
A 69-year-old woman undergoes follow-up evaluation for stage III colon cancer, which was resected 2 years ago. She is asymptomatic and takes no medications. Following a physical exam and surveillance CT scan that reveals two lesions in the right lobe of the liver, what is the most appropriate treatment?
https://immattersacp.org/weekly/archives/2022/01/25/3.htm
25 Jan 2022
Higher fecal hemoglobin concentration on FIT may support shorter screening interval
Patients with a hemoglobin concentration on fecal immunochemical testing (FIT) in the range directly below the positive result cutoff had significantly increased risk of adenoma on follow-up screening compared to those with lower results, a new analysis from Germany found.
https://immattersacp.org/weekly/archives/2023/11/07/2.htm
7 Nov 2023
Low-value cancer screening may be commonly provided to older U.S. adults
An observational study found that patients often continued to be screened for cervical, breast, and colorectal cancer after passing guideline-recommended age thresholds.
https://immattersacp.org/weekly/archives/2021/08/17/4.htm
17 Aug 2021
ACP issues new guidance on colorectal cancer screening
For asymptomatic, average-risk patients ages 50 to 75 years, the guidance suggests use of a fecal immunochemical test (FIT) or high-sensitivity guaiac-based fecal occult blood test every two years, colonoscopy every 10 years, or flexible sigmoidoscopy every 10 years plus FIT every two years.
https://immattersacp.org/weekly/archives/2019/11/05/1.htm
5 Nov 2019